Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Janssen - Advanced prostate cancer: How do we move forward in patient management?

Non metastatic castration resistant prostate cancer translating benefit to clinical practice & Choosing the right pathway in the current and future management of metastatic castration resistant prostate cancer

Date

14 Sep 2020

Session

Janssen - Advanced prostate cancer: How do we move forward in patient management?

Presenters

Nicolas Mottet

Authors

B.A. Hadaschik1, K.N. Chi2, E. Efstathiou3, N. Mottet4

Author affiliations

  • 1 Department Of Urology, University Hospital of Essen, 45147 - Essen/DE
  • 2 Medical Oncology Department, BC Cancer Agency - Vancouver, V5Z 4E6 - Vancouver/CA
  • 3 The M. D. Anderson Cancer Center, 77030 - Houston/US
  • 4 Uro-oncology Department, CHU Saint Etienne - Hopital Nord, 42055 - Saint-Étienne/FR
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings